Faecal immunochemical tests for occult blood testing should not be used outside of bowel screening: an audit of a large general practice
Related Experiment Video
Updated: Dec 26, 2025

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
Ui Ho Byun1, Neil Anderson2, Arlo Upton3
1Department of Surgery, University of Auckland, 85 Park Road, Grafton, Auckland, New Zealand; and Corresponding author.
Insights
The faecal immunochemical test (FIT) is a screening tool for bowel cancer. This audit found FIT was often used inappropriately in general practice, highlighting the need for adherence to national screening programme guidelines.
Area of Science:
- Gastroenterology
- Oncology
- General Practice
Background:
- The faecal immunochemical test (FIT) is increasingly used in bowel cancer screening programs globally.
- Current recommendations advise against using FIT outside of national screening programmes.
- This study examines the appropriate use of FIT in a general practice setting.
Purpose of the Study:
- To audit the appropriate use of faecal immunochemical tests (FIT) in general practice.
- To assess adherence to guidelines discouraging FIT use outside the National Bowel Screening Programme.
Main Methods:
- Data from 184 FIT tests requested in a multiclinic general practice (May 2017-May 2018) were extracted.
- Patient characteristics, test results, clinical rationale, referrals, and evaluation completeness were recorded.
- Analysis focused on the appropriateness of FIT requests based on clinical indications.
Main Results:
- FIT was primarily requested for changes in bowel habit (53%) and blood in stool (15%).
- Seven colorectal cancers were detected, all in patients with positive FIT results.
- A significant proportion of tests (10%) were ordered for reassurance, and 9% lacked a recorded indication.
Conclusions:
- FIT is a screening tool, and direct referral is recommended for symptomatic patients.
- Inappropriate use of FIT in general practice may delay necessary investigations and lead to false reassurance.
- Adherence to national screening programme guidelines for FIT is crucial.
Abstract:
INTRODUCTION The faecal immunochemical test (FIT) detects small quantities of human haemoglobin in faeces. This test has increasingly become the screening tool of choice in bowel cancer screening programmes worldwide, including New Zealand's upcoming national screening programme. AIM This study audited the appropriate use of faecal immunochemical tests (FIT) in general practice as current recommendations discourage the use of FIT outside the National Bowel Screening Programme. METHODS Data on all FIT requested by a multiclinic general practice serving 16000 patients from May 2017 to May 2018 were extracted from clinical records. Patient characteristics, results of tests, clinical rationale for the test, number of referrals and results and the completeness of clinical evaluation were recorded. RESULTS In all, 184 patients received an FIT, with 13 (7.1%) positive and 145 (78.8%) negative tests, and 26 (14.1%) tests declined by the laboratory. Nine patients (69.2%) with a positive FIT, 12 patients (8.1%) with a negative FIT and one patient (3.8%) with a declined test were referred to gastroenterology services. Seven colorectal cancers were detected, all in patients with a positive FIT who were aged between 67 and 91 years. FIT was requested most for changes in bowel habit (53%) and blood in stool (15%); 10% of tests were ordered for reassurance and 9% did not record an indication for the test. Two general practitioners (of 17 in the practice) accounted for over half of all tests requested. CONCLUSIONS Because FIT is only a screening tool for colorectal cancer, direct referral is recommended for symptomatic patients. Although cancers were detected only in patients with positive FITs, these patients would have qualified for direct referral for definitive investigation, and a referral was made concurrently. Awaiting test results may also delay necessary referrals and a negative FIT may produce false reassurance.
More Related Videos
04:57Comparative Analysis of Automatic Fecal Analyzer versus Direct Wet Smear Microscopy for Detecting Parasitic Infections in Stool Samples
Published on: April 25, 2025
08:42Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016